ONWRF (Onward Medical NV) ROCE %: -64.98% (As of Dec. 2025)


ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.96
GF Value $154.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV ROCE %?

Onward Medical NV ONWRF 37 ROCE % is -64.98% as of Dec. 2025. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $154.42 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Onward Medical NV's annualized ROCE % for the quarter that ended in Dec. 2025 was -64.98%.

Onward Medical NV  (OTCPK:ONWRF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Onward Medical NV ROCE % Related Terms

Onward Medical NV ROCE % Historical Data

* Premium members only.

The historical data trend for Onward Medical NV's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV ROCE % Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only -51.31 -36.76 -67.14 -64.12 -58.94

Onward Medical NV Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.30 -100.33 -57.10 -74.92 -64.98
ONWRF
37GF Score
Onward Medical NV ONWRF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onward Medical NV ROCE % Calculation

Onward Medical NV's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-45.972/( ( (79.725 - 9.729) + (99.008 - 12.996) )/ 2 )
=-45.972/( (69.996+86.012)/ 2 )
=-45.972/78.004
=-58.94 %

Onward Medical NV's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-45.168/( ( (65.065 - 12.062) + (99.008 - 12.996) )/ 2 )
=-45.168/( ( 53.003 + 86.012 )/ 2 )
=-45.168/69.5075
=-64.98 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -64.98% mean?
Onward Medical NV (ONWRF) has a ROCE % of -64.98% as of Dec. 2025.
Is Onward Medical NV's ROCE % too high?
Onward Medical NV's current ROCE % is -64.98%. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's ROCE % compare to VRTX and REGN?
Onward Medical NV's ROCE % of -64.98% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Onward Medical NV's current ROCE % is -64.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current ROCE % is -64.98%. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current ROCE % is -64.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • ROCE %: -64.98%
  • GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.96
Price
$154.42
GF Value